Last reviewed · How we verify
NCT04078685: COBRA-PATH
Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias
NA trial testing Standard catheter ablation in Tachycardia; Paroxysmal, Supraventricular in 113 participants. Status unknown.
9 March 2020
Quick facts
| Lead sponsor | Erasmus Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 113 |
| Start date | 12 June 2018 |
| Primary completion | 9 March 2020 |
| Estimated completion | 20 March 2021 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Standard catheter ablation
- Contact Force-sensing-based catheter ablation
Conditions studied
- Tachycardia; Paroxysmal, Supraventricular — all drugs for Tachycardia; Paroxysmal, Supraventricular →
- Tachycardia, Supraventricular — all drugs for Tachycardia, Supraventricular →
Sponsor
Erasmus Medical Center
Who can join
18 and older, any sex, with Tachycardia; Paroxysmal, Supraventricular or Tachycardia, Supraventricular. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this single-center prospective randomized controlled trial is to assess the superiority of contact-force-(CF)-sensing-based approach compared to conventional (non-CF-sensing) approach in the catheter ablation of PSVTs, and to investigate the safety of open-irrigated, contact-force-sensing ablation catheters (used in a "non-irrigated" mode) in these procedures.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH): a randomized controlled trial.
Geczy T, Ramdat Misier NL, Szili-Torok T. · · 2020 · cited 5× · PMID 32272969 · DOI 10.1186/s13063-020-4219-1
Verify or expand the search:
- PubMed search for NCT04078685
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Erasmus Medical Center trials
Trials by the same sponsor.
- NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
- NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
- NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
- NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
- NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04078685 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
- Last refreshed: 3 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04078685.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing